Total submissions: 12
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Laboratory for Molecular Medicine, |
RCV000036317 | SCV000059969 | benign | not specified | 2015-09-28 | criteria provided, single submitter | clinical testing | p.Tyr60Tyr in exon 2 of TPM1: This variant is not expected to have clinical sign ificance because it does not alter an amino acid residue and is not located with in the splice consensus sequence. It has been identified in 0.9% (98/10336) of A frican chromosomes by the Exome Aggregation Consortium (ExAC, http://exac.broadi nstitute.org; dbSNP rs17850194). |
Gene |
RCV000036317 | SCV000169035 | benign | not specified | 2013-04-11 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Invitae | RCV000226718 | SCV000285665 | benign | Hypertrophic cardiomyopathy | 2024-01-29 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000252086 | SCV000320345 | likely benign | Cardiovascular phenotype | 2016-12-02 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
ARUP Laboratories, |
RCV000036317 | SCV001159424 | likely benign | not specified | 2019-06-02 | criteria provided, single submitter | clinical testing | |
Color Diagnostics, |
RCV001190413 | SCV001357893 | benign | Cardiomyopathy | 2018-11-25 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000036317 | SCV004038011 | benign | not specified | 2023-08-19 | criteria provided, single submitter | clinical testing | |
All of Us Research Program, |
RCV000226718 | SCV004815438 | benign | Hypertrophic cardiomyopathy | 2024-02-05 | criteria provided, single submitter | clinical testing | |
Diagnostic Laboratory, |
RCV001530147 | SCV001744870 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics, |
RCV000036317 | SCV001924052 | benign | not specified | no assertion criteria provided | clinical testing | ||
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV000036317 | SCV001959584 | benign | not specified | no assertion criteria provided | clinical testing | ||
Cohesion Phenomics | RCV000226718 | SCV003803071 | benign | Hypertrophic cardiomyopathy | 2022-09-27 | no assertion criteria provided | clinical testing |